3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
15
Phase 1/2
5
Phase 1
4
Phase NA
3
Phase 3
2
Phase 2/3
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Sarcoma
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma
8
Liposarcoma
8
Hemangiosarcoma
8
Fibrosarcoma
8
Lymphoma, Large B-Cell, Diffuse
7
Sarcoma, Synovial
6
Rhabdomyosarcoma
6
Neurofibrosarcoma
6
Malignant mesenchymal tumor
6
Leukemia
6
Leiomyosarcoma
6
Histiocytoma, Malignant Fibrous
6
Hemangiopericytoma, Malignant
6
Testicular Neoplasms
5
Teratoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Testicular Germ Cell Tumor
4
Ovarian Neoplasms
4
Lymphoma, Non-Hodgkin
4
Endodermal Sinus Tumor
4
Seminoma
3
Neuroblastoma
3
Neoplasm Metastasis
3
Lymphoma, Follicular
3
Hodgkin Disease
3
Carcinoma, Embryonal
3
Interventions
Methotrexate
4
Doxorubicin
3
Ifosfamide
2
Etoposide
2
Cisplatin
2
sodium thiosulfate
1
peginterferon alfa-2b
1
merphos
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Tranexamic Acid
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Specimen Handling
1
Sodium Chloride
1
Restraint, Physical
1
Platinum
1
IMVP-16 protocol
1
Granulocyte Colony-Stimulating Factor
1
Fluoridation
1
Filgrastim
1
Fentanyl
1
Docetaxel
1
Cyproheptadine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Osteosarcoma
×
Ifosfamide
×
Clear all
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts